Teneligliptin (hydrobromide hydrate), CAS [[1572583-29-9]]

Produktübersicht

• Artikelname: Teneligliptin (hydrobromide hydrate), CAS [[1572583-29-9]]
• Artikelnummer: MCE-HY-14806B
• Hersteller Artikelnummer: HY-14806B
• Alternativnummer: MCE-HY-14806B-25MG,MCE-HY-14806B-5MG,MCE-HY-14806B-250MG,MCE-HY-14806B-100MG,MCE-HY-14806B-10MG,MCE-HY-14806B-50MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: MP-513 (hydrobromide hydrate)

Produktbeschreibung

Teneligliptin (MP-513) hydrobromide hydrate is an orally active and selective dipeptidyl peptidase 4 (DPP-4) inhibitor (IC50s: 0.37 and 0.29 nM for the human and rat DPP-4, respectively). Teneligliptin hydrobromide hydrate improves blood glucose levels and can be used in researches related to type 2 diabetes mellitus[1][2][3][4][5][6][7][8].

Produkteigenschaften

• Molekulargewicht: 426.58
• Reinheit: 99.97
• CAS Nummer: [1572583-29-9]
• Formel: C22H30N6OS
• Target-Kategorie: AMPK,Apoptosis,Interleukin Related,JNK,NF-kappaB,NOD-like Receptor (NLR),p38 MAPK,Reactive Oxygen Species (ROS),Toll-like Receptor (TLR)

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound